Edited and reviewed by: Erica Duncan, Emory University, United States
This article was submitted to Molecular Psychiatry, a section of the journal Frontiers in Psychiatry
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
In the original article, there was an error. The testosterone concentration in section
A correction has been made within a single line in the section
Osmotic pumps were placed subcutaneously and connected thorough cannulas to supply either testosterone (25 mM ethanol stock solution diluted to 3% in artificial cerebrospinal fluid) or placebo (3% ethanol solution in artificial cerebrospinal fluid) to the medial amygdala (ALZET Osmotic Pumps, USA).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.